发布求助
文献互助 智能选刊 最新文献

NEJM Journal Watch最新文献

筛选
英文 中文
Time to Treatment and Outcomes in Basilar Artery Occlusion 基底动脉闭塞的治疗时间和结果
NEJM Journal Watch Pub Date : 2021-11-16 DOI: 10.1056/NEJM-JW.NA54250
S. Chaturvedi
{"title":"Time to Treatment and Outcomes in Basilar Artery Occlusion","authors":"S. Chaturvedi","doi":"10.1056/NEJM-JW.NA54250","DOIUrl":"https://doi.org/10.1056/NEJM-JW.NA54250","url":null,"abstract":"Basilar artery occlusion (BAO) has long been recognized as an acute stroke syndrome with poor prognosis. Endovascular thrombectomy (EVT) has been","PeriodicalId":19048,"journal":{"name":"NEJM Journal Watch","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-11-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85624572","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risk Score for Acute Kidney Injury After Percutaneous Coronary Intervention 经皮冠状动脉介入治疗后急性肾损伤的风险评分
NEJM Journal Watch Pub Date : 2021-11-16 DOI: 10.1056/NEJM-JW.NA54312
H. Krumholz, Sm
{"title":"Risk Score for Acute Kidney Injury After Percutaneous Coronary Intervention","authors":"H. Krumholz, Sm","doi":"10.1056/NEJM-JW.NA54312","DOIUrl":"https://doi.org/10.1056/NEJM-JW.NA54312","url":null,"abstract":"Contrast-associated acute kidney injury (AKI) after percutaneous coronary intervention (PCI) is a common complication that can increase the risk for","PeriodicalId":19048,"journal":{"name":"NEJM Journal Watch","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-11-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86007687","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Certain Categories of Persons Living with HIV Have Worse COVID-19 Outcomes 某些类别的艾滋病毒感染者的COVID-19预后较差
NEJM Journal Watch Pub Date : 2021-11-15 DOI: 10.1056/NEJM-JW.NA54275
K. Henry
{"title":"Certain Categories of Persons Living with HIV Have Worse COVID-19 Outcomes","authors":"K. Henry","doi":"10.1056/NEJM-JW.NA54275","DOIUrl":"https://doi.org/10.1056/NEJM-JW.NA54275","url":null,"abstract":"Previous reports of the impact of HIV infection on COVID-19's clinical course have left uncertainty about the interactions between those two conditions","PeriodicalId":19048,"journal":{"name":"NEJM Journal Watch","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89623439","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Health Status Benefit with Empagliflozin in Heart Failure with Preserved Ejection Fraction 恩格列净对保留射血分数的心力衰竭患者的健康状况有益
NEJM Journal Watch Pub Date : 2021-11-15 DOI: 10.1056/NEJM-JW.NA54311
H. Krumholz, Sm
{"title":"Health Status Benefit with Empagliflozin in Heart Failure with Preserved Ejection Fraction","authors":"H. Krumholz, Sm","doi":"10.1056/NEJM-JW.NA54311","DOIUrl":"https://doi.org/10.1056/NEJM-JW.NA54311","url":null,"abstract":"The industry-funded EMPEROR-Preserved (Empagliflozin Outcome Trial in Patients with Chronic Heart Failure with Preserved Ejection Fraction;","PeriodicalId":19048,"journal":{"name":"NEJM Journal Watch","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75276098","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Combining SGLT-2 Inhibitors and GLP-1–Receptor Agonists for CV Risk Reduction in Type 2 Diabetes 联合SGLT-2抑制剂和glp -1受体激动剂降低2型糖尿病心血管风险
NEJM Journal Watch Pub Date : 2021-11-15 DOI: 10.1056/NEJM-JW.NA54310
H. Krumholz, Sm
{"title":"Combining SGLT-2 Inhibitors and GLP-1–Receptor Agonists for CV Risk Reduction in Type 2 Diabetes","authors":"H. Krumholz, Sm","doi":"10.1056/NEJM-JW.NA54310","DOIUrl":"https://doi.org/10.1056/NEJM-JW.NA54310","url":null,"abstract":"There is much excitement about the emerging evidence on sodium–glucose cotransporter-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1)–receptor","PeriodicalId":19048,"journal":{"name":"NEJM Journal Watch","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84362687","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Announcing a Co-Editor-in-Chief of 宣布联合主编
NEJM Journal Watch Pub Date : 2021-11-15 DOI: 10.1056/NEJM-JW.NA54319
H. Krumholz, Sm
{"title":"Announcing a Co-Editor-in-Chief of","authors":"H. Krumholz, Sm","doi":"10.1056/NEJM-JW.NA54319","DOIUrl":"https://doi.org/10.1056/NEJM-JW.NA54319","url":null,"abstract":"Dear readers,I am so pleased to announce that Karol E. Watson, MD, PhD, FACC, an Associate Editor for NEJM Journal Watch Cardiology since 2015, will","PeriodicalId":19048,"journal":{"name":"NEJM Journal Watch","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80772851","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tricuspid Annuloplasty for Moderate Regurgitation During Mitral-Valve Surgery: Clinical Benefit Still Unclear 二尖瓣手术中中度返流的三尖瓣成形术:临床效果尚不清楚
NEJM Journal Watch Pub Date : 2021-11-15 DOI: 10.1056/NEJM-JW.NA54293
H. Herrmann
{"title":"Tricuspid Annuloplasty for Moderate Regurgitation During Mitral-Valve Surgery: Clinical Benefit Still Unclear","authors":"H. Herrmann","doi":"10.1056/NEJM-JW.NA54293","DOIUrl":"https://doi.org/10.1056/NEJM-JW.NA54293","url":null,"abstract":"Many patients undergoing mitral-valve surgery have associated tricuspid regurgitation (TR). Whether repair with tricuspid annuloplasty (TA) improves","PeriodicalId":19048,"journal":{"name":"NEJM Journal Watch","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72706669","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Angiotensin Receptor–Neprilysin Inhibition vs. ACE Inhibition in Acute Myocardial Infarction 血管紧张素受体-奈普利素抑制与急性心肌梗死的ACE抑制
NEJM Journal Watch Pub Date : 2021-11-15 DOI: 10.1056/NEJM-JW.NA54253
H. Krumholz, Sm
{"title":"Angiotensin Receptor–Neprilysin Inhibition vs. ACE Inhibition in Acute Myocardial Infarction","authors":"H. Krumholz, Sm","doi":"10.1056/NEJM-JW.NA54253","DOIUrl":"https://doi.org/10.1056/NEJM-JW.NA54253","url":null,"abstract":"Is the angiotensin receptor–neprilysin inhibitor sacubitril–valsartan superior to the angiotensin-converting–enzyme (ACE) inhibitor ramipril in","PeriodicalId":19048,"journal":{"name":"NEJM Journal Watch","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82865392","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Should We Perform Valve Replacement for Severe Asymptomatic Aortic Stenosis 严重无症状主动脉瓣狭窄是否应该进行瓣膜置换术
NEJM Journal Watch Pub Date : 2021-11-15 DOI: 10.1056/NEJM-JW.NA54307
D. Cohen
{"title":"Should We Perform Valve Replacement for Severe Asymptomatic Aortic Stenosis","authors":"D. Cohen","doi":"10.1056/NEJM-JW.NA54307","DOIUrl":"https://doi.org/10.1056/NEJM-JW.NA54307","url":null,"abstract":"Aortic valve replacement is indicated for patients with severe symptomatic aortic stenosis to improve both symptoms and long-term prognosis. For","PeriodicalId":19048,"journal":{"name":"NEJM Journal Watch","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79933780","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Early Exercise After Breast Cancer Surgery Improves Outcomes 乳腺癌手术后早期运动改善预后
NEJM Journal Watch Pub Date : 2021-11-12 DOI: 10.1056/NEJM-JW.NA54290
H. Kuerer
{"title":"Early Exercise After Breast Cancer Surgery Improves Outcomes","authors":"H. Kuerer","doi":"10.1056/NEJM-JW.NA54290","DOIUrl":"https://doi.org/10.1056/NEJM-JW.NA54290","url":null,"abstract":"Axillary lymph node dissection with or without comprehensive nodal irradiation causes arm and shoulder disability in breast cancer patients. With the","PeriodicalId":19048,"journal":{"name":"NEJM Journal Watch","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83226975","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信